Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
4.550
-0.100 (-2.15%)
At close: Dec 5, 2025, 4:00 PM EST
4.600
+0.050 (1.10%)
After-hours: Dec 5, 2025, 7:25 PM EST
Annovis Bio Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -24.88 | -24.59 | -56.2 | -25.33 | -14.49 | -5.46 | |
| Other Amortization | - | - | - | - | - | 0 | |
| Stock-Based Compensation | 2.92 | 3.84 | 4.63 | 9.15 | 4.7 | 1.86 | |
| Other Operating Activities | -1.18 | -1.82 | 11.84 | - | - | 0.03 | |
| Change in Accounts Payable | -1.99 | 1.01 | -2.67 | 3.27 | 0.35 | -0.7 | |
| Change in Other Net Operating Assets | 0.15 | -0.33 | 2.44 | -4.41 | 0.31 | 0.29 | |
| Operating Cash Flow | -24.98 | -21.89 | -39.97 | -17.31 | -9.13 | -3.97 | |
| Issuance of Common Stock | 27.63 | 26.69 | 17.34 | 0 | 46.74 | 12.04 | |
| Financing Cash Flow | 27.63 | 26.69 | 17.34 | 0 | 46.74 | 12.04 | |
| Net Cash Flow | 2.65 | 4.8 | -22.62 | -17.31 | 37.61 | 8.07 | |
| Levered Free Cash Flow | -15.61 | -12.17 | -23.75 | -7.93 | -3.73 | -3.02 | |
| Unlevered Free Cash Flow | -15.61 | -12.17 | -23.75 | -7.93 | -3.73 | -3.02 | |
| Change in Working Capital | -1.84 | 0.68 | -0.23 | -1.14 | 0.66 | -0.4 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.